Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F0KW5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,096
Award facts
- Contract value 100% obligated
- $23,095.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,095.76 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injections. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, completed on November 19, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. Dupixent is a biologic medication indicated for multiple conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making it a critical specialty pharmaceutical for federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp has demonstrated significant capacity to fulfill federal medical procurement requirements across multiple therapeutic domains. The company's substantial IDC with DLA enables it to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard, positioning it as a critical vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F0KW5?
SPE2DR26F0KW5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F0KW5 worth?
The government has obligated $23,096 on SPE2DR26F0KW5.
Is contract SPE2DR26F0KW5 an order under another contract?
Yes. SPE2DR26F0KW5 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0KW5 competed?
The extent of competition for SPE2DR26F0KW5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award